Samir Patel, MD
Dermatology · Mason, OHNPI 1073552261
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $790 of the $940 with a category attached, or 84.0%. 8 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 59.4% of the total. 2024 is the largest year on record at $453, 3.3 times the $138 reported in 2019. That places this record below the midpoint for dermatology clinicians in OH, where the typical reported total is $2,374.
Across 39 payments — averaging $24.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$559
- AbbVie$150
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$111
- Merz Pharmaceuticals, LLC$53
- Pfizer$30
- Genentech USA, Inc.$13
- plus $24 from 2 others
What the payments were for
- Grants$15016%
- Food & beverage$79084%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 28 | $559 |
| AbbVie | 1 | $150 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $111 |
| Merz Pharmaceuticals, LLC | 3 | $53 |
| Pfizer | 2 | $30 |
| Genentech USA, Inc. | 1 | $13 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
| Organogenesis Inc. | 1 | $12 |
How this compares
$940 in reported general payments places this provider in the 30th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 11 | $946 |
| Ketoconazole | 11 | $115 |
| Triamcinolone Acetonide | 16 | $110 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Mason
- Nathan WeirMason$74K
- Matthew ZirwasBexley$3.3M
- George DrewMarion$1.9M
- Rocco SerraoDayton$1.7M
- James LibeccoFairlawn$1.1M
- Pranav ShethWest Chester$978K
- Dawn MerrittAthens$844K
- Neil KormanCleveland$824K
- Joshua GrosshandlerWesterville$479K
- Lorie GottwaldToledo$460K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.